"Practical points "
"ERCP"
"endoscopic ultrasound (EUS) with FNA sampling"
"KRAS/GNAS mutation analyses 13"
"KRAS/GNAS mutation analyses 13"
Expected headings
"Fluoroscopy"
"ERCP"
"Main duct IPMN"
"Branch-duct IPMN"
"Practical points "
"Calcifications have been reported in retrospective imaging analyses of resected IPMN at an incidence of ~12.5% (range 5-20%) 14-18; however, the overall incidence of calcifications in all IPMNs (i.e. resected and unresected) is not known (c. 2023). Accordingly, calcifications are not a criterion in the Kyoto guidelines for the management of IPMN and are much more common in other pancreatic cystic lesions (e.g. serous cystadenomas)."
"Both a dedicated pancreatic CT protocol and pancreatic MRI/MRCP have been reported as having similar accuracy in the characterisation of pancreatic cystic lesions 13; however, guidelines recommend MRI as the modality of choice for IPMN follow-up."
"bulging duodenal papilla: due to mucinous distension of the ampulla of Vater; a less common but highly specific (>97%) finding 19"
"Calcifications have been reported in retrospective imaging analyses of resected IPMN at an incidence of ~12.5% (range 5-20%) 14-18; however, the overall incidence of calcifications in all IPMNs (i.e. resected and unresected) is not known (c. 2023). Accordingly, calcifications are not a criterion in the Kyoto guidelines for the management of IPMN and are much more common in other pancreatic cystic lesions (e.g. serous cystadenomas)."